FAC Explorer

Finding 1144344 (2024-003)

Significant Deficiency Repeat Finding
Requirement
AB
Questioned Costs
-
Year
2024
Accepted
2025-06-27
Audit: 360239
Organization: Hips (DC)
Auditor: Gelman Rosenberg & Freedman

AI Summary

  • Core Issue: The audit identified a repeat finding related to the Schedule of Expenditures of Federal Awards (SEFA) for 2024.
  • Impacted Requirements: All programs listed in the SEFA for the year ended September 30, 2024, are affected.
  • Recommended Follow-Up: Review and address the issues from the previous finding (2023-004) to ensure compliance moving forward.

Finding Text

Finding 2024-003: Schedule of Expenditures of Federal Awards Information on the Federal Program: All programs in the 2024 SEFA. See Finding 2024-002 Questioned Costs: None. Context: The exception noted during the audit pertained to all programs under the SEFA for the year ended September 30, 2024. Identification as a Repeat Finding, if Applicable: Yes (2023-004)

Categories

Reporting

Other Findings in this Audit

  • 567890 2024-003
    Significant Deficiency Repeat
  • 567891 2024-003
    Significant Deficiency Repeat
  • 567892 2024-004
    Significant Deficiency Repeat
  • 567893 2024-005
    Significant Deficiency Repeat
  • 567894 2024-003
    Significant Deficiency Repeat
  • 567895 2024-004
    Significant Deficiency Repeat
  • 567896 2024-005
    Significant Deficiency Repeat
  • 567897 2024-003
    Significant Deficiency Repeat
  • 567898 2024-003
    Significant Deficiency Repeat
  • 567899 2024-003
    Significant Deficiency Repeat
  • 567900 2024-003
    Significant Deficiency Repeat
  • 567901 2024-003
    Significant Deficiency Repeat
  • 567902 2024-003
    Significant Deficiency Repeat
  • 1144332 2024-003
    Significant Deficiency Repeat
  • 1144333 2024-003
    Significant Deficiency Repeat
  • 1144334 2024-004
    Significant Deficiency Repeat
  • 1144335 2024-005
    Significant Deficiency Repeat
  • 1144336 2024-003
    Significant Deficiency Repeat
  • 1144337 2024-004
    Significant Deficiency Repeat
  • 1144338 2024-005
    Significant Deficiency Repeat
  • 1144339 2024-003
    Significant Deficiency Repeat
  • 1144340 2024-003
    Significant Deficiency Repeat
  • 1144341 2024-003
    Significant Deficiency Repeat
  • 1144342 2024-003
    Significant Deficiency Repeat
  • 1144343 2024-003
    Significant Deficiency Repeat

Programs in Audit

ALN Program Name Expenditures
93.788 Opioid Str $860,669
93.136 Injury Prevention and Control Research and State and Community Based Programs $491,878
93.940 Hiv Prevention Activities Health Department Based $108,444
93.944 Human Immunodeficiency Virus (hiv)/acquired Immunodeficiency Virus Syndrome (aids) Surveillance $105,173
93.243 Substance Abuse and Mental Health Services Projects of Regional and National Significance $72,996
93.421 Strengthening Public Health Systems and Services Through National Partnerships to Improve and Protect the Nation’s Health $2,463